Standard BioTools Inc. (LAB)

USD 1.99

(-10.18%)

Total Debt Summary of Standard BioTools Inc.

  • Standard BioTools Inc.'s latest annual total debt in 2023 was 98.21 Million USD , down -4.33% from previous year.
  • Standard BioTools Inc.'s latest quarterly total debt in 2024 Q2 was 90.55 Million USD , down -1.47% from previous quarter.
  • Standard BioTools Inc. reported annual total debt of 102.65 Million USD in 2022, down -8.05% from previous year.
  • Standard BioTools Inc. reported annual total debt of 111.64 Million USD in 2021, up 17.06% from previous year.
  • Standard BioTools Inc. reported quarterly total debt of 89.47 Million USD for 2024 Q3, down -1.19% from previous quarter.
  • Standard BioTools Inc. reported quarterly total debt of 91.89 Million USD for 2024 Q1, down -6.43% from previous quarter.

Annual Total Debt Chart of Standard BioTools Inc. (2023 - 2001)

Historical Annual Total Debt of Standard BioTools Inc. (2023 - 2001)

Year Total Debt Total Debt Growth
2023 98.21 Million USD -4.33%
2022 102.65 Million USD -8.05%
2021 111.64 Million USD 17.06%
2020 95.37 Million USD 59.02%
2019 59.97 Million USD -65.14%
2018 172.05 Million USD -11.87%
2017 195.23 Million USD 0.15%
2016 194.95 Million USD -0.37%
2015 195.68 Million USD 0.12%
2014 195.45 Million USD 0.0%
2013 - USD 0.0%
2012 - USD -100.0%
2011 10.13 Million USD -43.12%
2010 17.82 Million USD 23.26%
2009 14.46 Million USD -4.94%
2008 15.21 Million USD 5.94%
2007 14.35 Million USD -44.58%
2006 25.91 Million USD 0.0%
2001 - USD 0.0%

Peer Total Debt Comparison of Standard BioTools Inc.

Name Total Debt Total Debt Difference
Bionano Genomics, Inc. 87.94 Million USD -11.67%
Prenetics Global Limited 2.36 Million USD -4044.952%
Star Equity Holdings, Inc. 3.6 Million USD -2621.252%
CareDx, Inc 34.22 Million USD -186.988%
Exact Sciences Corporation 2.55 Billion USD 96.156%
Exagen Inc. 23.72 Million USD -314.021%
Inotiv, Inc. 417.64 Million USD 76.485%
Guardant Health, Inc. 1.35 Billion USD 92.745%
Biodesix, Inc. 60.69 Million USD -61.82%
BioNexus Gene Lab Corp. 133.39 Thousand USD -73523.449%
Precipio, Inc. 1.11 Million USD -8700.179%
iSpecimen Inc. 196.24 Thousand USD -49944.842%
Natera, Inc. 441.99 Million USD 77.78%
Aspira Women's Health Inc. 2.26 Million USD -4234.069%
23andMe Holding Co. 76.51 Million USD -28.354%
Castle Biosciences, Inc. 15.31 Million USD -541.476%
Personalis, Inc. 48.96 Million USD -100.584%
Aclaris Therapeutics, Inc. 426 Thousand USD -22953.991%
Applied DNA Sciences, Inc. 1.23 Million USD -7834.495%
OpGen, Inc. 13.04 Million USD -652.93%
T2 Biosystems, Inc. 49.49 Million USD -98.412%
Myriad Genetics, Inc. 145 Million USD 32.269%
ICON Public Limited Company 3.93 Billion USD 97.506%
NeoGenomics, Inc. 611.67 Million USD 83.944%
Star Equity Holdings, Inc. 3.6 Million USD -2621.252%
IDEXX Laboratories, Inc. 947.88 Million USD 89.639%
RadNet, Inc. 1.49 Billion USD 93.414%
MDxHealth SA 41.26 Million USD -137.998%
Psychemedics Corporation 2.29 Million USD -4173.716%
Illumina, Inc. 2.26 Billion USD 95.658%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 94.06 Million USD -4.402%
DarioHealth Corp. 29.54 Million USD -232.453%
Fulgent Genetics, Inc. 14.9 Million USD -558.818%
Sera Prognostics, Inc. 1.85 Million USD -5185.791%
ENDRA Life Sciences Inc. 394.4 Thousand USD -24800.926%
OPKO Health, Inc. 326.56 Million USD 69.926%
Medpace Holdings, Inc. 142.12 Million USD 30.897%
Neogen Corporation 906.23 Million USD 89.163%
Intelligent Bio Solutions Inc. 871.44 Thousand USD -11169.852%
Prenetics Global Limited 2.36 Million USD -4044.952%
Mainz Biomed B.V. 7.42 Million USD -1223.446%
bioAffinity Technologies, Inc. 1.57 Million USD -6121.182%
Trinity Biotech plc 67.42 Million USD -45.654%
Neuronetics, Inc. 62.47 Million USD -57.201%
Sotera Health Company 2.32 Billion USD 95.78%
bioAffinity Technologies, Inc. 1.57 Million USD -6121.182%